ABEONA THERAPEUTICS INC.
Developing AAV-based cell and gene therapies for serious and rare diseases.
ABEO | US
Overview
Corporate Details
- ISIN(s):
- US00289Y2063
- LEI:
- Country:
- United States of America
- Address:
- 6555 CARNEGIE AVE, 4TH FLOOR, 44103 CLEVELAND
- Website:
- https://abeonatherapeutics.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing cell and gene therapies for serious and rare diseases. The company's pipeline targets conditions with high unmet medical needs, including ophthalmic diseases like X-Linked Retinoschisis and Stargardt Disease, as well as Sanfilippo Syndrome and Infantile Batten Disease. Abeona develops adeno-associated virus (AAV)-based therapies and supports its programs through its in-house manufacturing facility, The Elisa Linton Center for Rare Disease Therapies. The company collaborates with partners such as Ultragenyx Pharmaceutical and Taysha Gene Therapies to advance its clinical development.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ABEONA THERAPEUTICS INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ABEONA THERAPEUTICS INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ABEONA THERAPEUTICS INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
